financetom
Business
financetom
/
Business
/
Vicor Insider Sold Shares Worth $360,706, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vicor Insider Sold Shares Worth $360,706, According to a Recent SEC Filing
Oct 29, 2025 10:02 AM

12:36 PM EDT, 10/29/2025 (MT Newswires) -- Alex Gusinov, Corporate Vice President, Engineering, on October 28, 2025, sold 4,019 shares in Vicor ( VICR ) for $360,706. Following the Form 4 filing with the SEC, Gusinov has control over a total of 12,680 common shares of the company, with 12,680 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/751978/000165492525000003/xslF345X05/primary_doc.xml

Price: 92.16, Change: +2.51, Percent Change: +2.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GURU Organic Energy Receives TSX Approval to Renew Normal Course Issuer Bid
GURU Organic Energy Receives TSX Approval to Renew Normal Course Issuer Bid
Jul 23, 2024
08:37 AM EDT, 07/23/2024 (MT Newswires) -- GURU Organic Energy ( GUROF ) said Tuesday that it secured TSX approval to renew its normal course issuer bid. The bid allows the company to purchase up to about 1.5 million shares or about 5% of its outstanding shares, for a year beginning on July 25. The company said repurchasing the shares...
Mesoblast Says FDA Accepted Resubmitted Biologics License Application for Ryoncil; Shares Rise Pre-Bell
Mesoblast Says FDA Accepted Resubmitted Biologics License Application for Ryoncil; Shares Rise Pre-Bell
Jul 23, 2024
08:34 AM EDT, 07/23/2024 (MT Newswires) -- Mesoblast (MESO) said Tuesday the US Food and Drug Administration has accepted the company's resubmitted biologics license application for Ryoncil, or remestemcel-L, to treat children with steroid-refractory acute graft versus host disease. The FDA considers the resubmission complete, with a decision expected by Jan. 7, 2025. Mesoblast said it resubmitted the application on...
Automotive Manufacturer Polaris Shares Tumble On Q2 Earnings Miss And Guidance Cut Amid Inventory Focus
Automotive Manufacturer Polaris Shares Tumble On Q2 Earnings Miss And Guidance Cut Amid Inventory Focus
Jul 23, 2024
Polaris Inc. ( PII )  shares are trading lower after the company reported worse-than-expected second-quarter financial results and cut its guidance. The company reported adjusted earnings per share of $1.38, missing the analyst consensus of $2.23. Quarterly sales of $1.961 billion missed the street view of $2.180 billion and were down 12% year over year. Lower volume and net pricing...
Aya Gold & Silver Expands Footprint and Outlines Multiple New Conductive Anomalies at Boumadine
Aya Gold & Silver Expands Footprint and Outlines Multiple New Conductive Anomalies at Boumadine
Jul 23, 2024
08:34 AM EDT, 07/23/2024 (MT Newswires) -- Aya Gold & Silver ( AYASF ) on Tuesday announced preliminary results from its recently completed regional geophysical survey of Boumadine in Morocco, noting that the results highlight multiple potential conductive anomalies. The preliminary results identify multiple, potentially highly conductive anomalies and drill-ready targets to the south of Boumadine Main Trend and to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved